# Rocket Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 6, 2026

- Company: [Rocket Pharmaceuticals, Inc.](/companies/rckt.md) (CIK 1281895)
- Form: DEF 14A
- Filed: 2026-04-06
- Accepted by EDGAR: Apr 6, 2026, 16:06 ET
- Period: 2026-05-20
- Accession: 0001140361-26-013335
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/ny20067122x2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1281895/000114036126013335/ny20067122x2_def14a.htm

Filed Apr 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-013335. Last ingested by Listed: Nov 5, 2026, 15:30 ET. No prices; not investment advice.